Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-12-08

Clinical Trial Update: Combination Chemotherapy Plus Bevacizumab With or Without Oxaliplatin in Treating Older Patients With Metastatic Colorectal Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating combination chemotherapy plus bevacizumab with or without oxaliplatin for metastatic colorectal cancer in older patients; the study was…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Avastin (bevacizumab)
  • Eloxatin (oxaliplatin)

Snippet

Sponsor: Alliance for Clinical Trials in Oncology | Conditions: Cognitive/Functional Effects, Colorectal Cancer | Phase 3 | Status: TERMINATED | Results posted: 2017-12-08